FORM 10-QSB

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                   QUARTERLY REPORT UNDER SECTION 13 OR 15 (D)

                     OF THE SECURITIES EXCHANGE ACT OF 1934

For Quarter Ended June 30, 2000


Commission File Number 1-8635

                          AMERICAN MEDICAL ALERT CORP.
        (Exact Name of Small Business Issuer as Specified in its Charter)

New York                                             11-2571221
(State or other jurisdiction of                      (I.R.S. Employer
incorporation or organization)                       Identification Number)

                3265 Lawson Boulevard, Oceanside, New York 11572
                    (Address of principal executive offices)
                                   (Zip Code)

                                 (516) 536-5850
                (Issuer's telephone number, including area code)

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Securities  Exchange  Act of 1934  during the  preceding  12
months (or for such shorter period that the registrant was required to file such
reports),  and (2) has been subject to such filing  requirements for the past 90
days. Yes X No ___

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest  practicable  date:  6,415,241 shares of $.01 par
value common stock as of August 10, 2000.


<PAGE>


                          AMERICAN MEDICAL ALERT CORP.
                                      INDEX

                          PART I. FINANCIAL INFORMATION
<TABLE>
<CAPTION>
                                                                                                        PAGE
<S>                                                                                                      <C>
Item 1.        Financial Statements.

               Report of Independent Accountants                                                         1

               Condensed Consolidated Balance Sheets for June 30, 2000                                   2
               and December 31, 1999

               Condensed Consolidated Statements of Income for the                                       3
               Six Months Ended June 30, 2000  and 1999

               Condensed Consolidated Statements of Income for the                                       4
               Three Months Ended June 30, 2000 and 1999

               Condensed Consolidated Statements of Cash Flows for                                       5
               the Six Months Ended June 30, 2000 and 1999

               Notes to Condensed Consolidated Financial Statements                                      6

Item 2.        Management's Discussion and Analysis of                                                   8
               Financial Condition and Results of Operations.


                                          PART II. OTHER INFORMATION

Item 4.        Submission of Matters to a Vote of Security-Holders.                                      12

Item 6.        Exhibits and Reports on Form 8-K.                                                         12

</TABLE>
<PAGE>


REPORT OF INDEPENDENT ACCOUNTANTS

Board of Directors and Shareholders
American Medical Alert Corp. and Subsidiary
Oceanside, New York

We have reviewed the condensed  consolidated  balance sheet of American  Medical
Alert  Corp.  and  Subsidiary  as of June  30,  2000 and the  related  condensed
consolidated statements of income for the three-month and six-month periods then
ended and cash  flows for the six  month  period  then  ended.  These  financial
statements are the responsibility of the company's management.

We conducted our review in accordance with standards established by the American
Institute  of  Certified  Public  Accountants.  A review  of  interim  financial
information consists principally of applying analytical  procedures to financial
data and making  inquiries of persons  responsible  for financial and accounting
matters. It is substantially less in scope than an audit conducted in accordance
with  generally  accepted  auditing  standards,  the  objective  of which is the
expression of an opinion  regarding the financial  statements  taken as a whole.
Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material  modifications that should
be made to the condensed consolidated financial statements referred to above for
them to be in conformity with generally accepted accounting principles.

We have  previously  audited,  in accordance  with generally  accepted  auditing
standards,  the  consolidated  balance  sheet as of December 31,  1999,  and the
related consolidated  statements of income,  shareholders' equity and cash flows
for the year then ended (not presented herein); and in our report dated February
17, 2000 we expressed an  unqualified  opinion on those  consolidated  financial
statements.  In our  opinion,  the  information  set  forth in the  accompanying
condensed  consolidated balance sheet as of December 31, 1999, is fairly stated,
in all material  respects,  in relation to the  consolidated  balance sheet from
which it has been derived.

The accompanying condensed consolidated statements of income for the three-month
and six month period ended June 30, 1999 and cash flows for the six-months ended
June 30, 1999 of American  Medical Alert Corp. and  Subsidiary  were not audited
(or reviewed) by us, and accordingly, we do not express an opinion (or any other
form of assurance) on them.


August 10, 2000                                   /s/Margolin, Winer & Evens LLP


                                      -1-
<PAGE>


PART I.      FINANCIAL INFORMATION

ITEM 1.           FINANCIAL STATEMENTS.

                          AMERICAN MEDICAL ALERT CORP.
                      CONDENSED CONSOLIDATED BALANCE SHEETS
                                     ASSETS
<TABLE>
<CAPTION>
                                                                                        June 30,2000         December 31,1999*
                                                                                         (Unaudited)         -----------------
                                                                                         -----------
CURRENT ASSETS:
<S>                                                                                        <C>                    <C>
         Cash                                                                              $ 308,468              $ 953,734
         Accounts and notes receivable
         (net of allowance for doubtful accounts of $75,000)                               2,718,621              2,255,640
         Inventory                                                                           588,480                791,572
         Prepaid expenses and other current assets                                           623,147                342,548
         Deferred income tax benefit                                                         156,000                156,000
                                                                                           ---------              ---------

         Total Current Assets                                                             $4,394,716             $4,499,494

INVENTORY OF MEDICAL DEVICES HELD FOR LEASE-AT COST                                        1,371,420                988,000
FIXED ASSETS:
         (Net of accumulated depreciation and amortization)                                6,683,345              5,503,347
OTHER ASSETS                                                                               1,177,257                393,680
                                                                                           ---------              ---------

TOTAL ASSETS                                                                             $13,626,738            $11,384,521
                                                                                         -----------            -----------

                                            LIABILITIES AND SHAREHOLDER'S EQUITY

CURRENT LIABILITIES:

         Accounts payable                                                                  $ 726,072              $ 305,320
         Accrued expenses                                                                    386,413                242,373
         Current portion of long-term debt                                                   259,554                 98,801
                                                                                           ---------              ---------
         Total Current Liabilities                                                         1,372,039                646,494

DEFERRED INCOME TAX LIABILITY                                                                436,000                423,000

DEFERRED INCOME                                                                               11,766                 17,166
LONG-TERM DEBT - LESS CURRENT MATURITIES                                                   1,539,798                282,686
                                                                                           ---------              ---------

Total Liabilities                                                                          3,359,603              1,369,346

COMMITMENTS AND CONTINGENT LIABILITIES

SHAREHOLDERS' EQUITY

             Preferred stock, $ .01 par value - authorized, 1,000,000 shares; none
                issued and outstanding
             Common stock - $.01 par value; authorized - 20,000,000 shares
                in 2000 and 10,000,000 shares in 1999; issued 6,458,021 shares
                in 2000 and 6,446,832 shares in 1999.                                      $  64,580               $ 64,468

             Additional paid-in capital                                                    6,226,895              6,200,701
             Retained earnings                                                             4,081,692              3,856,038
                                                                                           ---------              ---------
                                                                                          10,373,167             10,121,207
             Less 43,910 shares of treasury stock, at cost                                ( 106,032)              (106,032)
                                                                                           ---------              ---------
             Total Shareholders' Equity                                                   10,267,135             10,015,175
                                                                                           ---------              ---------

TOTAL LIABILITIES & SHAREHOLDERS' EQUITY                                                 $13,626,738            $11,384,521
                                                                                         -----------            -----------
</TABLE>

See accompanying notes to condensed financial statements.
             * Derived from audited financial statements

                                      -2-
<PAGE>
                          AMERICAN MEDICAL ALERT CORP.

                   CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                                   (Unaudited)
<TABLE>
<CAPTION>
                                                                                                     Six Months Ended June 30,
                                                                                                     -------------------------
                                                                                                   2000                    1999
                                                                                                   ----                    ----
Revenues:
<S>                                                                                               <C>                    <C>
         Services                                                                                 $4,917,073             $4,296,790
         Product Sales                                                                               188,164                158,892
                                                                                                  ----------             ----------
                                                                                                   5,105,237              4,455,682

Cost and Expenses (Income):
         Costs related to services                                                                 2,110,920              1,610,561
         Costs of products sold                                                                      145,834                151,593
         Selling, general and administrative expenses                                              2,439,241              1,835,813
         Interest expense                                                                             38,075                  9,901
            Other income                                                                            (16,487)               (13,258)
                                                                                                  ----------             ----------
                                                                                                   4,717,583              3,594,610
                                                                                                  ----------             ----------
Income before Provision for Income Taxes                                                             387,654                861,072

            Provision for Income Taxes                                                               162,000                371,000
                                                                                                  ----------             ----------

NET INCOME                                                                                         $ 225,654               $490,072
                                                                                                   =========              =========
Net Income per Share:
         Basic                                                                                       $   .04                $   .08
                                                                                                  ----------             ----------
         Diluted                                                                                     $   .04                $   .08
                                                                                                  ----------             ----------

Weighted average number of common shares outstanding (Note 3):

         Basic                                                                                     6,410,584              6,371,601
                                                                                                   =========              =========
         Diluted                                                                                   6,415,317              6,510,911
                                                                                                   =========              =========
</TABLE>

See accompanying notes to condensed financial statements



                                      -3-
<PAGE>

                          AMERICAN MEDICAL ALERT CORP.

                   CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                                   (Unaudited)
<TABLE>
<CAPTION>
                                                                                      Three months Ended June 30,
                                                                                      ---------------------------
                                                                                       2000                  1999
                                                                                       ----                  ----
Revenues:
<S>                                                                               <C>                  <C>
         Services                                                                 $ 2,527,899          $ 2,182,117
         Product Sales                                                                106,734               77,508
                                                                                  -----------          -----------
                                                                                    2,634,633            2,259,625

Cost and Expenses (Income):
         Costs related to service                                                   1,115,526              806,292
         Costs of products sold                                                        92,456               73,148
         Selling, general and
           administrative expenses                                                  1,303,670              948,549
         Interest expense                                                              23,768                4,386
         Other income                                                                 (7,575)              (5,731)
                                                                                  -----------          -----------
                                                                                    2,526,845            1,826,644
                                                                                  -----------          -----------

Income before Provision for Income Taxes                                              106,788              432,980

Provision for Income Taxes                                                             44,000              183,000
                                                                                  -----------          -----------


NET INCOME                                                                           $ 62,788             $249,980
                                                                                  -----------          -----------

Net Income per Share

         Basic                                                                        $   .01              $   .04
                                                                                  -----------          -----------
         Diluted                                                                      $   .01              $   .04
                                                                                  -----------          -----------

Weighted average number of common shares outstanding (Note 3):

         Basic                                                                      6,414,111            6,377,922
                                                                                  -----------          -----------
         Diluted                                                                    6,414,111            6,420,739
                                                                                  -----------          -----------
</TABLE>

See accompanying notes to condensed financial statements.


                                      -4-
<PAGE>
                          AMERICAN MEDICAL ALERT CORP.
                 CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
                                   (Unaudited)
<TABLE>
<CAPTION>
                                                                                                    Six Months Ended June 30,
                                                                                                    ------------------------
                                                                                                     2000              1999
Cash Flows from Operating Activities:
<S>                                                                                              <C>                <C>
         Net income                                                                              $ 225,654          $ 490,072
         Adjustments to reconcile net income to
            net cash provided by operating activities
         Depreciation and amortization                                                             831,554            582,606
            Loss on unrecovered leased medical equipment                                            56,150             58,772
            Change in Assets and Liabilities:
            (Increase) Decrease in receivables                                                    (462,981)           141,420
            (Increase) Decrease in inventory                                                       203,092           (540,313)

            Increase in prepaid expenses, deferred taxes and other assets                         (249,470)          (253,659)
            Increase in accounts payable, accrued
              expenses, taxes payable and deferred income                                          510,193            256,199
                                                                                                ----------         ----------

Net Cash Provided by Operating Activities                                                        1,114,192            735,097

Cash Flows from Investing Activities:
           Net expenditures for fixed assets                                                    (2,429,381)        (1,180,180)
           Proceeds from sale and leaseback of equipment                                           250,179                 -0-
           Payment for account acquisitions                                                       (353,011)                -0-
           Increase in notes receivable                                                           (285,737)           (65,000)
                                                                                                ----------         ----------
Net Cash Used In Investing Activities                                                           (2,817,950)        (1,245,180)

Cash Flows from Financing Activities:
          Increase in notes payable - bank                                                       1,100,000                 -0-
          Proceeds from (repayment of) loans payable and capital
            lease obligations                                                                      (67,814)             9,117
          Proceeds upon exercise of stock options                                                   26,306             62,143
                                                                                                ----------         ----------
Net Cash Provided by Financing Activities                                                        1,058,492             71,260

Net Decrease in Cash                                                                              (645,266)          (438,823)
Cash, Beginning of Period                                                                          953,734          1,419,842
                                                                                                ----------         ----------
Cash, End of Period                                                                              $ 308,468          $ 981,019

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for:
          Interest                                                                                $ 38,075          $  9,901
                                                                                                ----------         ----------
          Income Taxes                                                                           $ 231,606          $ 319,780
                                                                                                ----------         ----------
</TABLE>

See accompanying notes to condensed financial statements

                                      -5-
<PAGE>


                          AMERICAN MEDICAL ALERT CORP.
              Notes to Condensed Consolidated Financial Statements
                                   (Unaudited)

1.   General:

         These  financial  statements  should  be read in  conjunction  with the
financial  statements  and notes  thereto for the year ended  December  31, 1999
included in the Company's Annual Report on Form 10-KSB.

2.   Results of Operations:

         In the opinion of  management,  the  accompanying  unaudited  condensed
financial  statements  contain  all  adjustments   (consisting  only  of  normal
recurring  accruals)  necessary to present  fairly the financial  position as of
June 30,  2000,  and the  results of  operations  and cash flows for the six and
three months ended June 30, 2000 and 1999.

         The accounting  policies used in preparing these  financial  statements
are the same as those described in the December 31, 1999 financial statements.

         The results of  operations  for the six and three months ended June 30,
2000 are not necessarily  indicative of the results to be expected for any other
interim period or for the full year.

3.   Earnings Per Share

         In February 1997, the Financial  Accounting Standards Board issued SFAS
No. 128,  "Earnings  per Share" which  changes the  methodology  of  calculating
earnings per share. SFAS No. 128 requires the disclosure of diluted earnings per
share  regardless of its difference  from basic earnings per share.  The Company
adopted SFAS No. 128 in December  1997.  Earnings per share data for the six and
three months ended June 30, 2000 and 1999 is presented in  conformity  with this
pronouncement.

         The  following  table  is  a  reconciliation   of  the  numerators  and
denominators in computing earnings per share:

                                      -6-
<PAGE>
<TABLE>
<CAPTION>

Six Months Ended June 30, 2000                               Income                Shares               Per-Share
------------------------------                             (Numerator)           (Denominator)            Amounts
                                                           -----------           -------------            -------
<S>                                                       <C>                           <C>                <C>
Basic EPS -
Income available to common   stockholders
Effect of dilutive securities -                           $    225,654                  6,410,584          $.04
  Options and warrants                                                                                     ====
Diluted EPS -
Income available to common                                          -0-                     4,733
  stockholders and assumed                                 -----------                  ---------
  converstions                                             $   225,654                  6,415,317          $.04
                                                           ===========                  =========          ====

Three Months Ended June 30, 2000
--------------------------------

Basic EPS -  Income available to
  common stockholders                                      $     62,788                 6,414,111          $.01
Effect of dilutive securities -
  Options and warrants                                              -0-                       -0-
Diluted EPS - Income available to                          ------------                 ---------          =====
  common stockholders and assumed
  conversions                                              $     62,788                 6,414,111          $.01
                                                           ------------                 ---------          =====


Six months Ended June 30, 1999
------------------------------
Basic EPS -Income available to common
  stockholders                                             $       490,072              6,371,601          $.08
Effect of dilutive securities -
  Options and warrants                                                 -0-                139,310
Diluted EPS -Income available to                           ---------------              ---------
  common  stockholders and
  assumed conversions                                      $       490,072              6,510,911          $.08
                                                           ===============              =========          ====



Three Months Ended June 30, 1999
--------------------------------
Basic EPS - Income available to
  common stockholders                                      $       249,980              6,377,922          $.04
Effect of dilutive securities -
  Options and warrants                                                 -0-                 42,817
Diluted EPS -Income available to                           ---------------              ---------          ====
  common stockholders and assumed
  conversions                                              $       249,980              6,420,739          $.04
                                                           ---------------              ---------          ====
</TABLE>

                                      -7-
<PAGE>

4.       Major Customers:

                  The Company is an approved  Medicaid Provider in the states of
New York, Georgia and Illinois,  amongst others. During the three months and six
months ended June 30, 2000 and 1999 the Company had revenue from a contract with
the City of New York, Human Resources Administration, Home Care Services Program
(HCSP) which represented, respectively, 36% of total revenue in the 2000 periods
and 46% of total revenue in the 1999 periods. The contract was effective through
June 30, 1999.  In January 1999,  the Company  submitted its proposal to HCSP to
renew and extend the contract. Since June 30, 1999, the Company has continued to
provide service while awaiting its selection of a provider, and as of August 11,
2000,  the  contract  had  not  been  awarded.   The  Company  has  had  various
communications with HCSP with respect to the contract,  as described below under
the section  "Liquidity and Capital  Resources" of  Management's  Discussion and
Analysis.  Even if the Company does receive the renewal of the  contract,  there
can be no assurance  that the same level of revenues  will be sustained due to a
variety of factors including pricing,  number of subscribers to be serviced, the
competitive nature of the bid process, and the amount of time that passes before
the renewal agreement is acted upon by the  municipality.  Depending on how HCSP
may award the  renewal of the  agreement,  pricing on an  individual  subscriber
basis may be lower than current levels.  If HCSP does not renew the contract,  a
significant  amount of the Company's  revenue would be lost,  which would have a
material adverse effect on operating results, and in addition, there most likely
would be a  significant  write-down  of the  Company's  leased  medical  devices
(and/or a reduction in their  remaining  useful lives) and medical  devices held
for lease. The extent of the write down will be dependent upon the length of the
transition period to the new provider. As of June 30, 2000 and December 31, 1999
accounts receivable from the contract represented 62% of accounts receivable and
leased medical  devices in service under the contract  represented  35% and 38%,
respectively, of leased medical devices. In addition, inventory relating to this
contract  represents  approximately  20% of total  inventory on hand at June 30,
2000 and  December  31,  1999,  respectively.  At June 30,  2000 the Company has
incurred legal and other fees of approximately $218,000 relating to the contract
extension.  Such  costs  have  been  classified  as  deferred  costs and will be
amortized  over the new  contract  term or written  off if the  contract  is not
renewed.

ITEM 2. MANAGEMENT'S  DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS.

The following  discussion and analysis  provides  information  which  management
believes is relevant to an assessment and understanding of the Company's results
of  operations  and  financial  condition.  The  discussion  should  be  read in
conjunction with the consolidated  financial  statements contained in the latest
Annual Report dated December 31, 1999.

This  discussion  contains  forward-looking  statements  which,  in  addition to
assuming a  continuation  of the degree and timing of customer  utilization  and
rate of renewals of contracts with the Company at historical levels, are subject
to a number of known and unknown  risks that,  in addition to general  economic,
competitive  and  other  business   conditions,   could  cause  actual  results,
performance  and  achievements  to differ  materially  from those  described  or
implied in the forward-looking statements.

LIQUIDITY AND CAPITAL RESOURCES
-------------------------------

The Company has amended,  subject to formal documentation,  its Revolving Credit
Facility (the "Facility").  The Facility, which will expire on May 31, 2002, was
increased to $2,500,000

                                      -8-
<PAGE>

(based upon 75% of eligible accounts receivable and 50% of inventory, as defined
in the agreement  with respect to the Facility).  Borrowings  under the Facility
bear  interest  at the lower of the prime  rate or the LIBOR Rate plus 2.50% and
are  collateralized by the Company's assets.  There is $1,100,000 and $1,300,000
outstanding  under  the  Facility  as of June 30,  2000  and  August  10,  2000,
respectively.  The agreement with respect to the Facility  provides for negative
and affirmative covenants including those related to tangible net worth, working
capital  and other  borrowings.  At  December  31,  1999  there  were no amounts
outstanding under the Facility.

The  Company's  working  capital on June 30, 2000 was  $3,022,677 as compared to
$3,853,000 on December 31, 1999.  During 2000, the Company  anticipates  that it
will make capital investments of approximately $4,000,000 of which approximately
$2,400,000 was expended during the six months ended June 30, 2000. Of the amount
expended  in the  first six  months  approximately  $2,000,000  was used for the
design,  production and purchase of additional  systems that the Company intends
to rent. The balance of $400,000 has been used primarily for the  enhancement of
management information systems.

During the six months  ended June 30,  2000,  the Company made a secured loan of
$300,000 to a provider  agency to assist that agency with the  expansion  of its
PERS business. In addition,  as part of the Company's acquisition strategy,  the
Company  paid  $353,000  during the six months  ended June 30,  2000 to purchase
and/or convert to its systems, various local and national provider agencies. The
Company  believes  that its  present  cash and  working  capital  position,  its
borrowing  availability and future anticipated income will be sufficient to meet
its cash and working capital needs for the foreseeable future.

The Company derives a significant  portion of its revenue from one contract with
the City of New York's Human Resources  Administration  (HRA), Medicaid Homecare
Services  Program (HCSP).  During the three months and six months ended June 30,
2000 and 1999, the Company had revenue from this contract, which represented 36%
of total  revenue  in the 2000  periods  and 46% of  total  revenue  in the 1999
periods. As of June 30, 2000 and December 31, 1999, accounts receivable from the
contract  represented  62% of accounts  receivable.  Leased  medical  devices in
service  relating  to this  contract  represented  35% and 38% of  total  leased
medical devices at June 30, 2000 and December 31, 1999, respectively.  Inventory
relating to this contract  represented  approximately  20% of total inventory on
hand at June 30, 2000 and  December 31, 1999,  respectively.  The contract  with
HCSP  expired on June 30,  1999 and the  Company  continues  to service New York
City's Medicaid  Homecare Services Program (HCSP) under the terms and conditions
of the contract that expired.

In January 1999, the Company and several other companies  submitted proposals to
provide  PERS  services on behalf of the City of New York through June 30, 2003.
On October 22,  1999,  the Company was advised by HCSP that  another  vendor had
been  preliminarily  recommended.   The  Company's  management  reviewed  HCSP's
preliminary  recommendation  and  assessed  alternative  options  and courses of
action.  On November 1, 1999, the Company submitted a formal protest pursuant to
paragraph 4-04 of the Rules of the  Procurement  Policy Board of the City of New
York to contest the preliminary  award. In July, the Agency's Chief  Contracting
Officer advised the Company that the award had not yet been made. It was further
stated that this protest had not  persuaded the Agency to not award the contract
to the other vendor. The Company, believing in the merit of its protest appealed
this  determination  in accordance  with the  procurement  rules relating to the
contract to the  Commissioner  of HRA. On August 9, 2000,  the


                                      -9-
<PAGE>

Company  received  notification  from the Commissioner of HRA that the appeal of
the  determination  of the Agency's Chief  Contracting  Officer was denied.  The
Company  continues to believe in the merit of its protest and is evaluating  all
possible options in connection with this most recent notification.  As of August
11,  2000,  the  contract  had not been  awarded.  The Company  continues as the
current vendor and current revenues and the current  subscriber base relating to
this  agreement have  increased  slightly  since the levels  achieved in the 2nd
quarter of 1999.

If the HCSP awards the  contract  to another  vendor,  approximately  36% of the
Company's  revenues would be lost, having a material adverse effect on operating
results and cash flows. In addition, it is possible that significant adjustments
to inventory and fixed assets  associated  with the contract would occur.  Based
upon a transition  method  selected by HCSP,  it could be expected that revenues
from HCSP would  continue on a  diminishing  scale until all units are  removed.
However,  at this time, no  determination  can be made on how the  transition to
another  vendor  would be  accomplished,  and in what time frame the  transition
would be made,  and thus the full  financial  impact  cannot be assessed at this
time. Even if the Company does receive the renewal of the contract, there can be
no assurance  that the same level of revenues will be sustained due to a variety
of  factors  including  pricing,  number  of  subscribers  to be  serviced,  the
competitive nature of the bid process, and the amount of time that passes before
the renewal agreement is acted upon by HCSP. Depending on how HCSP may award the
renewal of the agreement, pricing on an individual subscriber basis may be lower
than the current levels.

In light of the  possibility  that the  Company's  contract with HCSP may not be
renewed,  the Company's management has developed a business plan to minimize the
potential loss through  reduction in HCSP related overhead and the re-deployment
of assets to other  programs.  In  addition,  the  Company  focused on, and will
continue to build its subscriber base through  consumers,  healthcare  agencies,
health   maintenance   organizations,   durable  medical  equipment   providers,
retirement communities,  hospitals and other governmental agencies. In addition,
the Company is continuing to invest in new products, services, and initiatives.

RESULTS OF OPERATIONS
---------------------

Revenue from services  (recurring monthly revenues,  RMR) increased $620,283 for
the six months  ended June 30, 2000 as  compared to the same period in 1999,  an
increase of 14%, and increased $345,782 for the three months ended June 30, 2000
as  compared to the same  period in 1999,  an  increase of 16%.  The Company has
experienced  success in growing its customer  base outside the contract with the
City of New York through a variety of marketing  efforts that have  continued to
contribute to increasing RMR. In the first two quarters of fiscal year 2000, the
Company has doubled its net new  subscriber  growth,  independent of the City of
New York contract,  in comparison to fiscal year 1999. Costs related to services
as a percentage  of RMR for the six months ended June 30, 2000 and 1999 were 43%
and 37%, and for the three months ended June 30, 2000 and 1999 were 44% and 37%,
respectively. The increases in costs related to services resulted from increased
depreciation  of  medical  devices,   additional   response  center   personnel,
enhancement of the Company's information systems and personnel, and increases in
telecommunication  costs  resulting from the expansion of available  services to
subscribers.

Revenue from product  sales for the six months ended June 30, 2000 was $188,164,
an increase

                                      -10-
<PAGE>

of $29,292 as compared to the same period in 1999.  Revenue from  product  sales
for the three months ended June 30, 2000 was $106,734, an increase of $29,226 as
compared to the same period in 1999.  Gross profit on product  sales for the six
months ended June 30, 2000 and 1999 was 23% and 5%,  respectively.  Gross profit
on product  sales for the three  months ended June 30, 2000 and 1999 was 13% and
6%, respectively.  Gross profit increased in 2000 as a result of the sale of the
Company's new Model 450 Smart  Activator and sales of the Company's  products to
retirement facilities, which are at higher profit margins.

Selling,  general and administrative  expenses increased by $603,428 for the six
months  ended June 30, 2000 as compared to the same period in 1999,  an increase
of  33%.  Selling,  general,  and  administrative  expenses  as  compared  as  a
percentage  of total  revenues  for the six months  ended June 30, 2000 and 1999
were 48% and 41%,  respectively.  Selling,  general and administrative  expenses
increased  by $355,121  for the three  months ended June 30, 2000 as compared to
the  same  period  in  1999,  an  increase  of  37%.   Selling,   general,   and
administrative  expenses as compared as a percentage  of total  revenues for the
three  months  ended  June  30,  2000 and  1999  were 49% and 42%, respectively.
Additional  expenses incurred in 2000 were the result of the hiring of executive
and management personnel, expansion of the sales department, increased sales and
marketing  expenses,  and start up costs  associated with the development of the
Company's new subsidiary, Safe Com, Inc.

Interest expense for the six months ended June 30, 2000 and 1999 was $38,075 and
$9,901, respectively.  Interest expense for the three months ended June 30, 2000
and 1999 was $23,768 and $4,386,  respectively.  Interest in 2000 increased as a
result of additional borrowings needed to fund inventory and equipment needs for
new  subscribers,  management  systems,  and the start up of the  Company's  new
subsidiary, Safe Com, Inc.

The Company's  income before provision for income taxes for the six months ended
June 30,  2000 was  $387,654,  a decrease  of $473,418  from 1999,  or 55%.  The
Company's  income  before  provision for income taxes for the three months ended
June 30,  2000 was  $106,788,  a decrease  of $326,192  from 1999,  or 75%.  The
decrease in income  before  provision  for income taxes in 2000 resulted from
the factors noted above.

                                      -11-
<PAGE>

                           PART II. OTHER INFORMATION

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

The annual meeting of  shareholders of the Company was held on June 28, 2000 for
the purpose of: (i) electing five  directors,  (ii) approving the Company's 2000
Stock Option Plan, and (iii) approving an amendment to the Company's Articles of
Incorporation  to increase the number of authorized  shares of common stock, par
value $.01 per share ("Common  Stock") of the Company from ten million shares to
twenty million shares.

1.  The following directors were elected by the following vote:

                                                For                   Withheld
                                                ---                   --------
    Howard M. Siegel                         5,902,422                209,937
    Leonard Herz                             5,404,142                669,217
    Peter Breitstone                         5,697,542                405,817
    Theodore Simon                           5,404,142                692,217
    Frederic S. Siegel                       5,404,142                638,137

2.  The  proposal  to approve  the  Company's  2000 Stock  Option  Plan was
    approved by the following vote:

            For               Against             Abstain        Not Voted
         ------------       -----------       ---------------    ---------
          2,117,982          1,428,464             56,670        2,812,125


3.  The  proposal  to  approve  an  amendment  to  the  Company's   Articles  of
    Incorporation to increase the number of authorized shares of Common Stock of
    the Company  from ten million to twenty  million  shares was approved by the
    following vote:

                        For                Against           Abstain
                     ----------            -------           -------
                     5,632,660             432,561           195,388

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K.

(a) Exhibits:

         27.  Financial Data Schedule

(b) Reports on Form 8-K:

         No reports on Form 8-K were filed.

                                      -12-
<PAGE>

                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Company  has duly  caused  this  report to be  signed on its  behalf by the
undersigned thereunto duly authorized.

                          AMERICAN MEDICAL ALERT CORP.

Dated: August 11, 2000                By: /s/ Howard M. Siegel
                                         ---------------------------------------
                                           Howard M. Siegel
                                           President and Chief Operating Officer

                                      By: /s/ Corey M. Aronin
                                         ---------------------------------------
                                           Corey M. Aronin
                                           Chief Financial Officer

                                      -13-